Cargando…

Sphingolipids in cancer /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Chalfant, Charles, 1970- (Editor ), Fisher, Paul B. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Academic Press, 2018.
Colección:Advances in cancer research ; v. 140.
Temas:
Acceso en línea:Texto completo
Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_on1046977686
003 OCoLC
005 20231120010308.0
006 m o d
007 cr cnu---unuuu
008 180801s2018 enk ob 000 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d OPELS  |d N$T  |d GZM  |d YDX  |d EBLCP  |d OHS  |d OCLCO  |d CNCGM  |d OCLCO  |d UPM  |d OCLCF  |d OCLCO  |d NLE  |d UKMGB  |d D6H  |d OCLCO  |d OCLCQ  |d OCLCO  |d N$T  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d CASUM  |d OCLCO 
015 |a GBB8F0625  |2 bnb 
016 7 |a 019004850  |2 Uk 
019 |a 1047775463  |a 1048281416  |a 1110183928 
020 |a 9780128142240  |q (electronic bk.) 
020 |a 0128142243  |q (electronic bk.) 
020 |z 9780128142233 
020 |z 0128142235 
035 |a (OCoLC)1046977686  |z (OCoLC)1047775463  |z (OCoLC)1048281416  |z (OCoLC)1110183928 
050 4 |a QP752.S6 
060 4 |a QU 85 
072 7 |a SCI  |x 007000  |2 bisacsh 
082 0 4 |a 572/.57  |2 23 
245 0 0 |a Sphingolipids in cancer /  |c edited by Charles E. Chalfant, Paul B. Fisher. 
264 1 |a London :  |b Academic Press,  |c 2018. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in cancer research,  |x 0065-230X ;  |v v. 140 
588 0 |a Online resource; title from PDF title page (ScienceDirect, viewed August 2, 2018). 
505 0 |a Front Cover; Advances in Cancer Research; Advances in Cancer Research:Sphingolipids in Cancer; Contents; CONTRIBUTORS; FOREWORD; PREFACE; One -- Mechanisms of Ceramide-Dependent Cancer Cell Death; 1. INTRODUCTION; 2. SPHINGOLIPID METABOLISM AND CANCER; 2.1 Structure and Metabolism of Sphingolipids; 2.2 Enzymes of Ceramide Metabolism and Cancer; 2.2.1 Serine Palmitoyltransferase; 2.2.2 Ceramide Synthases 1-6; 2.2.3 Dihydroceramide Desaturase (DES or DEGS1); 2.2.4 Sphingomyelinases; 2.2.5 Sphingomyelin Synthases and Ceramide Transporter; 2.2.6 Ceramide Kinase; 2.2.7 Glucosylceramide Synthase 
505 8 |a 2.2.8 Ceramidases3. CERAMIDE IN CANCER CELL DEATH; 3.1 Ceramide and Apoptosis; 3.2 Ceramide and Necroptosis; 3.3 Ceramide and Lethal Autophagy or Mitophagy; 3.4 Ceramide and Endoplasmic Reticulum Stress; 3.5 Ceramide and Cell Cycle Arrest; 4. SPHINGOLIPID METABOLISM AND ANTICANCER THERAPY; 4.1 Ceramide Generation in the Induction of Chemotherapy/Radiation-Mediated Tumor Suppression; 4.2 Ceramide Metabolism in Tumor Immunology and Immunotherapy; 4.2.1 Targeting Sphingolipid Metabolism and Signaling for Cancer Therapy; 5. DISCUSSION; ACKNOWLEDGMENTS; REFERENCES; FURTHER READING 
505 8 |a Two -- Sphingolipids as Regulators of Autophagy and Endocytic Trafficking1. INTRODUCTION; 2. THE MOLECULAR MACHINERY OF AUTOPHAGY AND REGULATION BY SPHINGOLIPIDS; 2.1 Autophagy Initiation: the Unc-51-Like Kinase Complex; 2.1.1 Sphingolipids in Autophagy Initiation; 2.2 Phagophore Nucleation: the Phosphatidylinositol 3-Kinase Complex; 2.2.1 Sphingolipids in Phagophore Nucleation; 2.3 Phagophore Elongation: LC3 Lipidation; 2.3.1 Sphingolipid-Mediated Regulation of LC3 Lipidation; 2.4 Phagophore Elongation: Membrane Delivery and Autophagic Cargo 
505 8 |a 2.4.1 Sphingolipid Regulation of Membrane Delivery and Autophagic Cargo2.5 Phagophore Closure; 2.6 Autophagosome-Lysosome Fusion; 2.6.1 Sphingolipids in Autophagosome Maturation; 3. SPHINGOLIPID-MEDIATED AUTOPHAGY IN CANCER: DR. JEKYLL AND MR. HYDE; 3.1 Dr. Jekyll: A Driver of Cancer Cell Survival; 3.2 Mr. Hyde: Inducer of Autophagy-Dependent Cancer Cell Death; 3.2.1 Lethal Mitophagy; 3.2.2 Autophagic Cell Death by Noncanonical Autophagy; 3.2.3 Autophagy-Dependent Lysosomal Membrane Permeabilization; 3.2.4 Autophagy-Dependent Noncanonical Caspase-8 Activation 
505 8 |a 3.2.5 Autophagy-Dependent Apoptosis via the Calpain-Mediated Cleavage of ATG54. CONCLUSION AND FUTURE DIRECTIONS; REFERENCES; Three -- Role and Function of Sphingomyelin Biosynthesis in the Development of Cancer; 1. STRUCTURE AND INTRACELLULAR DISTRIBUTION OF SPHINGOMYELIN; 2. THE SPHINGOMYELIN SYNTHASE ENZYMES; 3. FUNCTIONS OF THE LIPIDS REGULATED BY THE SPHINGOMYELIN SYNTHASE REACTION; 3.1 Sphingomyelin; 3.1.1 Regulation of Lipid Microdomains in the Outer Leaflet of the Plasma Membrane and Impact on Receptor-Mediated Signaling 
504 |a Includes bibliographical references. 
650 0 |a Sphingolipids. 
650 2 |a Neoplasms  |0 (DNLM)D009369 
650 2 |a Sphingolipids  |0 (DNLM)D013107 
650 6 |a Sphingolipides.  |0 (CaQQLa)201-0086675 
650 7 |a SCIENCE  |x Life Sciences  |x Biochemistry.  |2 bisacsh 
650 7 |a Sphingolipids  |2 fast  |0 (OCoLC)fst01129699 
655 4 |a Internet Resources. 
655 4 |a Index not Present. 
700 1 |a Chalfant, Charles,  |d 1970-  |e editor. 
700 1 |a Fisher, Paul B.,  |e editor. 
776 0 8 |i Print version:  |t Sphingolipids in cancer.  |d London : Academic Press, 2018  |z 0128142235  |z 9780128142233  |w (OCoLC)1020030438 
830 0 |a Advances in cancer research ;  |v v. 140.  |x 0065-230X 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/bookseries/0065230X/140  |z Texto completo 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780128142233  |z Texto completo